158 related articles for article (PubMed ID: 34438937)
1.
Qureshi KA; Al Nasr I; Koko WS; Khan TA; Fatmi MQ; Imtiaz M; Khan RA; Mohammed HA; Jaremko M; Emwas AH; Azam F; Bholay AD; Elhassan GO; Prajapati DK
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438937
[TBL] [Abstract][Full Text] [Related]
2.
Qureshi KA; Azam F; Fatmi MQ; Imtiaz M; Prajapati DK; Rai PK; Jaremko M; Emwas AH; Elhassan GO
PeerJ; 2023; 11():e14502. PubMed ID: 36935926
[TBL] [Abstract][Full Text] [Related]
3. Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X
Qureshi KA; Bholay AD; Rai PK; Mohammed HA; Khan RA; Azam F; Jaremko M; Emwas AH; Stefanowicz P; Waliczek M; Kijewska M; Ragab EA; Rehan M; Elhassan GO; Anwar MJ; Prajapati DK
Sci Rep; 2021 Jul; 11(1):14539. PubMed ID: 34267232
[TBL] [Abstract][Full Text] [Related]
4. Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of
Qureshi KA; Imtiaz M; Al Nasr I; Koko WS; Khan TA; Jaremko M; Mahmood S; Fatmi MQ
Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139985
[TBL] [Abstract][Full Text] [Related]
5. Identification, Bioactivity, and Productivity of Actinomycins from the Marine-Derived
Wang D; Wang C; Gui P; Liu H; Khalaf SMH; Elsayed EA; Wadaan MAM; Hozzein WN; Zhu W
Front Microbiol; 2017; 8():1147. PubMed ID: 28702007
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
Sharma M; Manhas RK
BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
[TBL] [Abstract][Full Text] [Related]
7. A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity.
Chen C; Song F; Wang Q; Abdel-Mageed WM; Guo H; Fu C; Hou W; Dai H; Liu X; Yang N; Xie F; Yu K; Chen R; Zhang L
Appl Microbiol Biotechnol; 2012 Aug; 95(4):919-27. PubMed ID: 22543353
[TBL] [Abstract][Full Text] [Related]
8. Asp-containing actinomycin and tetracyclic chromophoric analogues from the
Zhao W; Wang G; Guo L; Wang J; Jing C; Liu B; Zhao F; Zhang S; Xie Z
Org Biomol Chem; 2023 Feb; 21(8):1737-1743. PubMed ID: 36723156
[TBL] [Abstract][Full Text] [Related]
9. Actinomycins produced by endophyte Streptomyces sp. GLL-9 from navel orange plant exhibit high antimicrobial effect against Xanthomonas citri susp. citri and Penicillium italicum.
Gao L; Kumaravel K; Xiong Q; Liang Y; Ju Z; Jiang Y; Zhang J
Pest Manag Sci; 2023 Nov; 79(11):4679-4693. PubMed ID: 37450767
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
11. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES
Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Streptomyces MITKK-103, a newly isolated actinomycin X2-producer.
Kurosawa K; Bui VP; VanEssendelft JL; Willis LB; Lessard PA; Ghiviriga I; Sambandan TG; Rha CK; Sinskey AJ
Appl Microbiol Biotechnol; 2006 Aug; 72(1):145-154. PubMed ID: 16374634
[TBL] [Abstract][Full Text] [Related]
13. Discovery of actinomycin L, a new member of the actinomycin family of antibiotics.
Machushynets NV; Elsayed SS; Du C; Siegler MA; de la Cruz M; Genilloud O; Hankemeier T; van Wezel GP
Sci Rep; 2022 Feb; 12(1):2813. PubMed ID: 35181725
[TBL] [Abstract][Full Text] [Related]
14. Unveiling the Targets Involved in the Quest of Antileishmanial Leads Using In silico Methods.
Boniface PK; Sano CM; Elizabeth FI
Curr Drug Targets; 2020; 21(7):681-712. PubMed ID: 32003668
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting
Sakyi PO; Kwofie SK; Tuekpe JK; Gwira TM; Broni E; Miller WA; Wilson MD; Amewu RK
Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986430
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S
Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596
[TBL] [Abstract][Full Text] [Related]
17. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
[TBL] [Abstract][Full Text] [Related]
18. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
Sousa JKT; Antinarelli LMR; Mendonça DVC; Lage DP; Tavares GSV; Dias DS; Ribeiro PAF; Ludolf F; Coelho VTS; Oliveira-da-Silva JA; Perin L; Oliveira BA; Alvarenga DF; Chávez-Fumagalli MA; Brandão GC; Nobre V; Pereira GR; Coimbra ES; Coelho EAF
Parasitol Int; 2019 Dec; 73():101966. PubMed ID: 31362122
[TBL] [Abstract][Full Text] [Related]
19. Computational studies on potential small molecule inhibitors of
Boakye A; Gasu EN; Mensah JO; Borquaye LS
J Biomol Struct Dyn; 2023; 41(21):12128-12141. PubMed ID: 36632757
[TBL] [Abstract][Full Text] [Related]
20. Leishmanicidal Potential of Hardwickiic Acid Isolated From
Crentsil JA; Yamthe LRT; Anibea BZ; Broni E; Kwofie SK; Tetteh JKA; Osei-Safo D
Front Pharmacol; 2020; 11():753. PubMed ID: 32523532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
